PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Feb-2022 The Scottish Medicines Consortium (SMC) approves diroximel fumarate as an oral treatment for relapsing-remitting multiple sclerosis (RRMS) Biogen UK
08-Feb-2022 vasopharm GmbH Announces Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury vasopharm GmbH
08-Feb-2022 Positive feedback from European Medicines Agency on XF-73 Nasal gel Phase 3 programme Destiny Pharma plc
08-Feb-2022 Oxurion to Participate in the 2022 BIO CEO and Investor Conference Oxurion
08-Feb-2022 Cytovation collaborates with Recurrent Respiratory Papillomatosis Foundation to expand its clinical investigations of CyPep-1 into rare neoplastic disease Cytovation AS
08-Feb-2022 Top 3 Trends To Transform Orthopedic Devices Market Forecast Through 2027 Global Market Insights
08-Feb-2022 Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform Koneksa
08-Feb-2022 MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan Businesswire
08-Feb-2022 Thermo Fisher Scientific Partners with Medidata Acorn AI to Optimize Clinical Research Site Selection and Speed Patient Enrollment in Clinical Trials Thermo Fisher Scientific
08-Feb-2022 Jazz/GW Pharmaceuticals receives approval for the reimbursement of EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex in Scotland Jazz Pharmaceuticals plc
08-Feb-2022 Record year for industrial biotechnology grants and investments Novo Nordisk
08-Feb-2022 Major Update to MIPI CSI-2 Camera Specification Enables Next Generation of Always On, Low Power, Machine Vision Applications Businesswire
08-Feb-2022 Celltrion submits Investigational New Drug (IND) application to initiate a global Phase III clinical trial evaluating an inhaled COVID-19 antibody cocktail therapy Celltrion
08-Feb-2022 n-Lorem Foundation Partners with Cytiva to Bring Individualized ASO Medicines to Patients with Nano-rare Diseases Businesswire
08-Feb-2022 FDA approves Enjaymoâ„¢ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Sanofi
08-Feb-2022 Worldwide Pharma Regulatory Management Systems Market Industry to 2027 - Increasing Pharma Business Expansion in Different Regulatory Territories - ResearchAndMarkets.com Businesswire
08-Feb-2022 Kintara Therapeutics Announces Issuance of New US Patent Related to VAL-083 and MGMT Resistance: Implications for Targeting Brain Tumor Stem Cells Kintara Therapeutics
08-Feb-2022 Amolyt Pharma Selected for the French Tech 120 Program Amolyt Pharma
08-Feb-2022 CORL Launches Innovative Medical Device Risk Assessment Toolkit Businesswire
08-Feb-2022 Iterative Scopes Announces AI-Driven Data Sharing Agreement with Pfizer to Advance IBD Clinical Trials Businesswire